Patient Power®
Get Email Alerts!
Health Topics
Melanoma Health Center
Health Center Home Audio Programs Videos
Search by Keyword:
Search by Health Topic:
View all Health Topics >

Exciting New Therapies for Advanced Melanoma

New clinical trials data presented at ASCO 2011 revealed a striking response to drugs ipilimumab (recently-approved), and vemurafenib, a new drug for patients with the most common subtype of advanced melanoma (B-RAF V600E Mutation). Dr. Kim Margolin, a Melanoma specialist at the Fred Hutchinson Cancer Research Institute in Seattle helped us understand why this new drug is making news and why patients have reason to be hopeful.

Health Topics: Melanoma, Skin Cancer

Get Email Updates:

Get updated automatically when new content about Melanoma has been posted.
Privacy Policy
MelanomaMore Health Topics

Experts & Guests

Kim Margolin, M.D. Kim Margolin, M.D.
Professor, University of Washington, Seattle Cancer Care Alliance
Dr. Margolin’s clinical efforts are in the treatment of melanoma, kidney cancer and germ cell cancer, and she is particularly interested in clinical trials that provide the newest investigational therapies for her patients. Melanoma and kidney cancer are often treated with immunotherapy, including vaccines, cytokines and immune-cell infusions. Germ cell cancer can be treated effectively with high-dose chemotherapy and autologous... more >

Related Videos

Hear Katie Bunker talk about surviving melanoma.

Watch Now
Dr. Lynn Schuchter discusses novel therapies and clinical trials for patients with advanced melanoma and what these new developments could mean in treating other cancers.

Watch Now